Some of the most promising disease modifying therapies being developed at the moment are based on drug repurposing (eg Exenatide/Ambroxol), making this webinar essential for anyone suffering from Parkinson's or caring for someone suffering from Parkinson's.

Dr Lorraine Kalia shares with us her expertise and brings us up to date with the latest news.

Dr. Lorraine Kalia is an associate professor and a clinician-scientist at the University of Toronto in Canada. She is dedicated to Parkinson's disease, both in her clinical practice as a movement disorders neurologist and in her research program as a neuroscientist.

She is the co-editor-in-chief of the Journal of Parkinson’s Disease and co-chair of the International Parkinson and Movement Disorder Society Scientific Issues Committee.

Her research focuses on understanding the fundamental molecular processes that lead to neurodegeneration in Parkinson’s disease and finding new therapies that can target these molecular culprits to slow down or even stop the disease.

Dr. Kalia recently presented at the World Parkinson's Congress in Barcelona.

More can be found out about the speaker here:-

https://lmp.utoronto.ca/faculty/lorra...

Website https://kalialabs.org/

To find out the latest trails if you are based in or around Toronto Email [email protected]